Chen, Junhan
Ikeda, Shin-ichi
Yang, Yajing
Zhang, Yan
Ma, Ziyan
Liang, Yifan
Negishi, Kazuno
Tsubota, Kazuo
Kurihara, Toshihide http://orcid.org/0000-0002-5457-2720
Funding for this research was provided by:
Japan Science and Technology Agency (Japan Science and Technology Agency)
Ministry of Education, Culture, Sports, Science and Technology (20K09834, 21H03096)
Japan Agency for Medical Research and Development (JP22gm1510007)
Tsubota Laboratory (Tsubota Laboratory)
Article History
Received: 31 July 2023
Accepted: 30 January 2024
First Online: 14 February 2024
Declarations
:
: The Animal Experimental Committee of Keio University approved all animal experiments conducted in this study (A2022-242), and the study adhered to the Institutional Guidelines on Animal Experimentation at Keio University, the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for the use of animals in research.
: Not applicable.
: J.C., None; S.I., None; T.K., None; Y.Y., None; Z.M., None; Y.L., None; Y.Z., None; T.K., None; K.T. reports his position as CEO of Tsubota Laboratory, Inc., Tokyo, Japan, a company producing myopia-related devices.